Resona Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Resona Asset Management's BMY Position: Q1 2026 in Review
Resona Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.79% in Q1 2026, selling an estimated $308K and leaving 664,074 shares worth $40.2M. The position accounts for 0.2% of the portfolio, ranked #100.
Resona Asset Management first reported a position in BMY in Q1 2024 and has held it in 9 quarters since. The position peaked at $42.2M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Resona Asset Management held 664,074 shares of Bristol-Myers Squibb worth $40.2M as of Q1 2026.
- Resona Asset Management sold 5,292 Bristol-Myers Squibb shares in Q1 2026, an estimated $308K.
- Bristol-Myers Squibb made up 0.2% of Resona Asset Management's portfolio in Q1 2026, its #100 holding.
- Resona Asset Management first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 9 quarters since.
- Resona Asset Management's Bristol-Myers Squibb position peaked at $42.2M in Q1 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Resona Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.